There are 2 on the market, but one seems to get better results. It is Vertex's telaprevir (brand name Incivek, (pronounced In-SEE-vik.) It is only taken for 24 weeks. It is like the combo, but with a 3rd drug (a protease inhibitor) added. The first 12 weeks include the protease inhibitor (the new, 3rd drug) with interferon and ribavirin, and the final weeks are the combo alone. Some may be asked to go longer on the combo part, depending on their response. Everyone will be able to get this drug, regardless of ability to pay or lack of insurance (or problems with insurance paying for it.)
The other drug is Merck's boceprevir (brand name Victrelis.) The protease inhibitor is in pill form with both drugs. I believe there is only one injection a week of the interferon in both cases.
I was planning to start the Incevik the moment it became available (late May), but because I have a new liver cancer and it was decided to evaluate me for transplant and treat the tumor, I wasn't able to get on it. I'm now on the transplant list and think it would be unlikely that I could start this treatment after TP, as they don't have data on the drug with post-transplant patients. So I imagine I will end up on the combo.
If Dennis's doctor thinks he's a good candidate for this treatment, I hope he goes for it--shorter treatment time and much higher response rate.
Hugs and best of luck. (I also see my hep doc on 9/6.)
Connie